ISSN: 0973-7510

E-ISSN: 2581-690X

Mahboubeh Babaee1 and Abdol Ghaffar Ebadi2
1Department of Laws, Jouybar branch, Islamic Azad University, Jouybar 47761-86131, Iran.
2Department of Agriculture, Jouybar branch, Islamic Azad University, Jouybar 47761-86131, Iran.
J. Pure Appl. Microbiol., 2016, 10 (1): 333-337
© The Author(s). 2016
Received: 13/06/2015 | Accepted: 19/09/2015 | Published: 31/03/2016
Abstract

Todays, the role of pharmaceutical and drug industries in Iranian medical economics and market are very eminent and reached to 80 billion dollars (15% of incomes in this region) because 96% of anti-microbial and anti-cancer drugs produce by Iranian companies. One of the main concerns in Iranian pharmaceutical sectors is about agreement on trade aspects of Intellectual Property laws (TRIPs. In this paper, with usage of recent findings from library references and also Iranian medical association, different aspects of Intellectual Property laws, limitations, Obstacles and other national and international effects in Iranian pharmaceutical and drugs industries will discuss. Based on results, Commitment related to proposed Intellectual Property laws by TRIPs should implement by all countries’ members like Iran and all members will give commitment and respect to Patents about pharmaceutical products and produce the generic form of drugs only when the duration time of patent is finished.

Keywords

Pharmaceutical and drug industries, Intellectual Property laws, Iran, Patent.

Article Metrics

Article View: 1247

Share This Article

Journal Tools

© The Author(s) 2016. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.